ShanX MedtechShanX Medtech
ShanX Medtech

ShanX Medtech

Develops in-vitro diagnostic platforms for rapid antimicrobial susceptibility testing.

Website
2019Active16
Advertise here

About

ShanX Medtech is developing novel diagnostics, specifically an ultra-rapid Antimicrobial Susceptibility Testing (AST) platform. This platform aims to provide sample-to-result turnaround times as fast as 1 hour, significantly reducing the current 2-7 day wait for AST results. By enabling faster identification of effective antibiotics, ShanX Medtech serves clinicians and patients by improving treatment outcomes and combating Antimicrobial Resistance.

Technology stack

detected 2026-06-14
Est. monthly stack spend~$220/mo
EmailSelf-hosted
Hosting
self_managed
Stack
jQueryBootstrapWordPress
SEO
Yoast SEO
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does ShanX Medtech do?

ShanX Medtech is developing novel diagnostics, specifically an ultra-rapid Antimicrobial Susceptibility Testing (AST) platform. This platform aims to provide sample-to-result turnaround times as fast as 1 hour, significantly reducing the current 2-7 day wait for AST results. By enabling faster identification of effective antibiotics, ShanX Medtech serves clinicians and patients by improving treatment outcomes and combating Antimicrobial Resistance.

How much funding has ShanX Medtech raised?

ShanX Medtech has raised a total of $28M in funding. The most recent round on record is Seed.

Where is ShanX Medtech headquartered?

ShanX Medtech is headquartered in San Diego, United States.

When was ShanX Medtech founded?

ShanX Medtech was founded in 2019.

What industry does ShanX Medtech operate in?

ShanX Medtech operates in HealthTech, Biotechnology, Diagnostics, MedTech, In-Vitro Diagnostics, Antimicrobial Resistance.

How many employees does ShanX Medtech have?

ShanX Medtech has approximately 16 people on record.